Filtered By:
Management: Funding

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 2110 results found since Jan 2013.

Greater executive dysfunction in patients post-COVID-19 compared to those not infected
Brain Behav Immun. 2023 Aug 14:S0889-1591(23)00237-4. doi: 10.1016/j.bbi.2023.08.014. Online ahead of print.ABSTRACTBACKGROUND: A number of patients post-coronavirus disease-19 (COVID-19) report cognitive impairment (CI), even months after acute infection. We aimed to assess if COVID-19 is associated with increased incidence of CI in comparison to controls.METHODS: We analyzed data from the Mount Sinai Health System Post-COVID-19 Registry in New York City, a prospective cohort of patients post-COVID-19 ≥18 years of age and non-infected controls. CI was defined by scores ≥1.0 standard deviation below population norms, a...
Source: Brain, Behavior, and Immunity - August 16, 2023 Category: Neurology Authors: Jacqueline H Becker Jenny J Lin Akosua Twumasi Ruchir Goswami Fernando Carnavali Kimberly Stone Monica Rivera-Mindt Minal S Kale Georges Naasan Joanne R Festa Juan P Wisnivesky Source Type: research

News at a glance: A win for obesity drugs, NIH unionization roadblocks, and Mexican fireflies under threat
CONSERVATION Researchers raise alarm over threat to Mexican fireflies Scientists from the International Union for Conservation of Nature (IUCN) last week delivered a letter to the Mexican government requesting it regulate tourism centered on the threatened firefly species Photinus palaciosi . Endemic to Mexico’s Tlaxcala forests, P. palaciosi is one of the few species that glow in synchrony, offering an annual spectacle that attracts thousands of visitors during summer mating season. The letter describes how littering, artificial light, and noise interfere with the insects’ courtship and eg...
Source: ScienceNOW - August 10, 2023 Category: Science Source Type: news

News at a glance: A win for obesity drugs, a new infectious disease institute head, and Mexican fireflies under threat
CONSERVATION Researchers raise alarm over threat to Mexican fireflies Scientists from the International Union for Conservation of Nature (IUCN) last week delivered a letter to the Mexican government requesting it regulate tourism centered on the threatened firefly species Photinus palaciosi . Endemic to Mexico’s Tlaxcala forests, P. palaciosi is one of the few species that glow in synchrony, offering an annual spectacle that attracts thousands of visitors during summer mating season. The letter describes how littering, artificial light, and noise interfere with the insects’ courtship and eg...
Source: Science of Aging Knowledge Environment - August 10, 2023 Category: Geriatrics Source Type: research

Long-running ProMED email service for alerting world to disease outbreaks is in trouble
The first news about the COVID-19 pandemic came not from a government or a scientific publication, but in an email from a disease-alert system called ProMED . This fateful missive in December 2019 about a few cases of a mysterious pneumonia in Wuhan, China, is just one example of how physicians and public health experts around the world have used the 30-year-old, free service to share real-time information about local disease outbreaks with tens of thousands of subscribers. But ProMED is now on life support. Much of its work came to a screeching halt yesterday when 21 of its 38 paid editors and moderators went o...
Source: Science of Aging Knowledge Environment - August 4, 2023 Category: Geriatrics Source Type: research

Experimental drugs in randomized controlled trials for long-COVID: what's in the pipeline? A systematic and critical review
Expert Opin Investig Drugs. 2023 Aug 4:1-13. doi: 10.1080/13543784.2023.2242773. Online ahead of print.ABSTRACTINTRODUCTION: Over three years have passed since the emergence of coronavirus disease 2019 (COVID-19), and yet the treatment for long-COVID, a post-COVID-19 syndrome, remains long overdue. Currently, there is no standardized treatment available for long-COVID, primarily due to the lack of funding for post-acute infection syndromes (PAIS). Nevertheless, the past few years have seen a renewed interest in long-COVID research, with billions of dollars allocated for this purpose. As a result, multiple randomized contro...
Source: Expert Opinion on Investigational Drugs - August 3, 2023 Category: Drugs & Pharmacology Authors: Shin Jie Yong Alice Halim Michael Halim Long Chiau Ming Khang Wen Goh Mubarak Alfaresi Bashayer M AlShehail Mona A Al Fares Mohammed Alissa Tarek Sulaiman Zainab Alsalem Ameen S S Alwashmi Faryal Khamis Nawal A Al Kaabi Hawra Albayat Ahmed Alsheheri Moham Source Type: research